Condition
Peritoneal Dialysis, Continuous Ambulatory
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
75% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (3)
P 1 (1)
P 2 (1)
Trial Status
Completed3
Terminated1
Unknown1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07113574Phase 2Completed
Pharmacokinetics of Meropenem and Aztreonam After Intraperitoneal Administration Via Cycler-therapy in APD Patients Without Peritonitis
NCT01478698Phase 1Terminated
The Safety and Tolerability of Intra-abdominal t-PA and DNase on Peritonitis in Peritoneal Dialysis Patients
NCT04427514Not ApplicableUnknownPrimary
Continuous Ambulatory Peritoneal Dialysis With Telemedicine
NCT01887262Not ApplicableCompletedPrimary
Control Of Fluid Balance Guided by Body Composition Monitoring in Patients on PeritoneAl dialySiS
NCT00563446Not ApplicableCompleted
Study of the Efficacy of Darbepoetin Alfa in the Treatment of Renal Anemia
Showing all 5 trials